EUA Approval Urgency Good possibility NeuroRX u
Post# of 144904
Good possibility NeuroRX unblinds and goes for authZ with the DSMC interim analysis underway for Relief Therapeutics Aviptadil and that is S/C patient trial.
As an aside they seem to be struggling with enrollment to get the trial completed despite the solid results from a case controlled open label study done in Houston.
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)